Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak, et al.
The Lancet (2024) Vol. 403, Iss. 10427, pp. 632-644
Closed Access | Times Cited: 217

Showing 51-75 of 217 citing articles:

Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments
Romi Gupta, Raj Kumar, Courtney A. Penn, et al.
Trends in Immunology (2025)
Closed Access
Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment
Ιωάννα Αγγελετοπούλου, Spyridon Pantzios, Christos Triantos
Cancers (2025) Vol. 17, Iss. 3, pp. 376-376
Open Access
Revolutionizing Nanovaccines: A New Era of Immunization
Mohammed A. Saleh, Ahmed El-Moghazy, Adel Helmy Elgohary, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 126-126
Open Access
Temozolomide‐Promoted MGMT Transcription Contributes to Chemoresistance by Activating the ERK Signalling Pathway in Malignant Melanoma
Meiyi Deng, Bingjie Ren, Jian Zhao, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 3
Open Access
Cross-priming in cancer immunology and immunotherapy
Carlos Luri‐Rey, Álvaro Teijeira, Stefanie K. Wculek, et al.
Nature reviews. Cancer (2025)
Closed Access
Individualized Neoantigen-Directed Melanoma Therapy
Karam Khaddour, Elizabeth I. Buchbinder
American Journal of Clinical Dermatology (2025)
Closed Access
Adjuvant Therapy in Renal Cell Carcinoma
Patrick L. Sweeney, Kelly N. Fitzgerald
Advances in Oncology (2025)
Closed Access
Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges
Sowmya Cheruvu, David McMahon, James Larkin
Expert Opinion on Biological Therapy (2025), pp. 1-12
Closed Access
Tailoring Nanovectors for Optimal Neoantigen Vaccine Efficacy
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
A personalized cancer vaccine to prevent the return of high-risk kidney cancer

Nature (2025)
Closed Access
Encouraging co-targeting of immunoregulatory molecules in cancer treatment
Takumi Sato, Yu Fujiwara
Immunotherapy (2025), pp. 1-4
Closed Access
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Katy A. Lloyd, Jim Middelburg, Vitalijs Ovcinnikovs, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Advancing Gene Therapy: Enzyme Selection For Effective RNA Oligonucleotide Mapping
Thomas Menneteau, Balasubrahmanyam Addepalli, Tatiana Johnston, et al.
Deleted Journal (2025), pp. 26-33
Closed Access
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
Apoorva Mehta, Mateen Motavaf, Ikenna David Nebo, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1200-1200
Open Access
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation
Chengyi Li, Fang Ke, Shuai Mao, et al.
ACS Nano (2025)
Open Access
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures
Maise Al Bakir, James L. Reading, Samuel Gamble, et al.
Nature (2025)
Open Access
The past, present, and future of RNA vaccines
John S. Tregoning, Niek N. Sanders
Molecular Therapy (2025)
Closed Access
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer
Remya Raja, Kiran K. Mangalaparthi, Anil K. Madugundu, et al.
Science Advances (2025) Vol. 11, Iss. 8
Closed Access
Clinical Approaches for the Management of Skin Cancer: A Review of Current Progress in Diagnosis, Treatment, and Prognosis for Patients with Melanoma
Christopher M. O Connor, Quinton L. Carr, Alisa Sweazy, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 707-707
Open Access
Interactions between the intestinal microbiota and drug metabolism – Clinical implications and future opportunities
Dianne Ford
Biochemical Pharmacology (2025), pp. 116809-116809
Open Access
Differential shaping of T cell responses elicited by heterologous ChAd68/self-amplifying mRNA SIV vaccine in macaques in combination with αCTLA4, αPD-1, or FLT3R agonist
Amy Rappaport, Elena Bekerman, Gregory R. Boucher, et al.
The Journal of Immunology (2025)
Closed Access
Adopting tomorrow’s therapies today: a perspective review of adoptive cell therapy in lung cancer
Faith Abodunrin, Daniel J. Olson, Oluwatosin Emehinola, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Adoptive T-Cell Therapy in Melanoma
Robert C. Chick, Joal D. Beane, Carlo M. Contreras
Surgical Oncology Clinics of North America (2025)
Closed Access

Scroll to top